Medical News TodayGut Microbiome Assemblage Impacts Response to Cancer ImmunotherapyGenetic Engineering & Biotechnology NewsUniversity of Chicago Medicine researchers report that specific microbiome assemblages can boost the response rate to immunother… Continue reading
Gene therapy normalises blood sugar levels in mice with type 1 diabetesDiabetes.co.ukA gene therapy approach has been shown to normalise blood glucose levels in mice with type 1 diabetes, and could one day be used to treat humans. The therapy involves … Continue reading
Gene therapy normalises blood sugar levels in mice with type 1 diabetesDiabetes.co.ukA gene therapy approach has been shown to normalise blood glucose levels in mice with type 1 diabetes, and could one day be used to treat humans. The therapy involves … Continue reading
Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 CatalystsMarkets InsiderSynlogic (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today provided an overview of … Continue reading
Los Angeles TimesGene therapy offers long-term treatment for mice with diabetesLos Angeles TimesNext, he said, his team will seek permission from the Food & Drug Administration to launch clinical trials using the viral gene therapy in patients with… Continue reading
ALS News Today |
Sangamo and Pfizer to Collaborate on Developing Gene Therapies for ALS
ALS News Today Sangamo Therapeutics and Pfizer will work together on gene therapies they hope will overcome mutations that cause ALS and frontotemporal lobar degeneration. Gene therapy works by delivering a healthy copy of a malfunctioning gene to a patient. The … Pfizer and Sangamo Partner on Gene Therapy for Lou Gehrig’s DiseaseBioPharm International Pfizer buys into Sangamo’s motor neuron disease gene therapyPMLiVE |
FierceBiotech |
Johnson & Johnson pens Alzheimer’s gene therapy pact
FierceBiotech The workaround being pursued by J&J is underpinned by AAV research performed by Jim Wilson, M.D., Ph.D. and others at the university’s gene therapy program. Wilson and his collaborators have been working to improve AAVs for more than two decades … |